Hardware Podcasts

Regulatory & Quality Perspectives of 3D Printing in the Medical Device Industry

Global Medical Device Podcast · 22 Jun 2022 · 45m · Episode 268

What this episode covers

Mike Drues of Vascular Sciences, joined by hosts Jon Speer and Etienne Nichols, explains the regulatory and quality distinctions between 3D printing and additive manufacturing, noting that over 100 3D-printed medical devices have received FDA clearance. Drues argues that for personalized, point-of-care devices like patient-specific stents or anatomical models, validation must focus on the manufacturing process rather than the individual product, as clinical trials for single-patient devices are infeasible. The discussion highlights the challenges of regulating point-of-care printing in settings ranging from cath labs to home garages, and the need for software certification and process validation to ensure safety without stifling innovation.

Most relevant to

early-stage companies

Topics

Mentioned

Companies
Green Light Guru, Vascular Sciences
Also
FDA, Green Light Guru Academy

Related episodes from other shows

Other shows on the same ground, closest first.

  • Additive Snack · 32m

    Unlocking the Potential: 3D Printing’s Impact on Medical Innovation and Beyond with Laura Gilmour

    Laura Gilmour, founder of LG Strategies and former global medical business development manager at EOS, discusses the adoption of additive manufacturing in the medical device industry. She details key applications including hearing aids, orthopedic implants with porous structures, and dental crowns, while highlighting regulatory hurdles from the FDA and insurance payers. Gilmour explains the importance of IQ, OQ, and PQ processes for quality assurance and outlines emerging trends like point-of-care manufacturing and bioprinting.

    Medical & health devicesCertification & compliance
    7 chapters

  • Additive Snack · 35m

    Evolving the Orthopedic Frontier: A Deep Dive into the History of Medical AM with Charles Hansford

    Chuck Hansford, Director of Advanced Development at Tecomet, discusses the evolution of metal additive manufacturing (AM) in the medical industry, noting that all top five orthopedic OEMs now use AM for production parts. He explains that while AM is a viable production technology, it remains in a developmental phase where every unique geometry requires specific process qualification, often taking years to gain OEM approval. Hansford highlights critical challenges such as trapped powder particles, the necessity of post-processing, and the importance of designing parts to be additive-conductive rather than simply printing subtractive models.

    Medical & health devicesDesign for manufacturing & NPI
    6 chapters

  • Predictable Designs Podcast · 1h 05m

    3D Printing and Additive Manufacturing with Steve Szymeczek of Penumbra Engineering

    Steve Szymeczek of Penumbra Engineering explains the practical applications of additive manufacturing for low-to-medium volume production, contrasting it with traditional injection molding. He details the cost-effectiveness of technologies like FDM and HP Multi-Jet Fusion for startups needing 100 to 10,000 units, emphasizing the importance of designing for injection molding even when using 3D printing for prototyping. Szymeczek also discusses the benefits of distributed manufacturing, material limitations, and the role of generative design in creating complex, value-added parts.

    Prototyping & iterationMaterials & manufacturing processes
    7 chapters

  • Let's Combinate · 1h 16m

    012 - "Asking then Seeing" with Sara Waxberg Mcnew

    Sara Waxberg McNew, Chief Scientific Officer at Design Science, explains the human factors process for medical devices, emphasizing the distinction between formative studies and summative validation. She details how to interpret ANSI/AAMI HE75 and IEC 62366-1 standards, manage risk for combination products, and handle regulatory submissions with the FDA. The discussion covers specific challenges like testing rare patient populations, using surrogates, and conducting threshold analyses for generics.

    Medical & health devicesValidation & product-market fit
    12 chapters

  • Additive Snack · 1h 02m

    When Production Overtakes Prototyping: Materialise’s Next Phase of AM

    Bart van der Schuren, CTO of Materialise, explains how the company transitioned from a 1995 service bureau to a production powerhouse, recently surpassing prototyping with serial manufacturing. He details the three pillars of Materialise—manufacturing, software, and medical applications—and highlights rapid adoption in hearing aids, dental, and drones, contrasted with the slow, recertification-heavy aerospace sector. Van der Schuren argues that AI-driven automation and in-situ quality control are critical for reducing New Product Introduction (NPI) costs and scaling production in regulated industries.

    Scaling productionAI & machine learning
    10 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.